Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07653464 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Interplay of Central and Peripheral Vascular Effects of Insulin in Obesity

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Oct 2026 to Dec 2026
    • Eligibility criteria expanded, about 21 words
  2. Start date: Aug 2026 to Oct 2026v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Determine the impact of obesity with insulin resistance on the neurovascular response to brain insulin stimulation.
Trial Details
NCT Number NCT07653464
Lead Sponsor University of Missouri-Columbia
Conditions
(from sponsor)		 Obesity (BMI>30), Insulin Resistance
Related terms Insulin Resistance, Obesity
Enrollment 64 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov